ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

Hammer Says He’ll Ask Reagan For Bigger NCI Budget

October 30, 1981

NCI Plans $40M In Grants For Cancer Outcomes Studies.

June 30, 2000

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

September 3, 1976

Group Chairmen Object To “Directive” Language In Proposed Intergroup Study Guidelines

January 13, 1984

Zydelig Tablets Approved For Three Blood Cancers

July 25, 2014

In Brief: Nobel Prize Awarded to Blobel for Research On Protein Signaling; Work Funded By NIH

October 15, 1999